Transgenic Companies in BioPortfolio's Corporate Database 
Transgenic company data on BioPortfolio. Our corporate data records list over 50,000 company records. Here you can see the latest Transgenic companies that have been added to our BioPortfolio's life-science corporate directory.
Search For More Transgenic Companies
If you don't find the company you're looking for in the list below, you may wish to search our extensive database for further matches: Search for More Transgenic Companies.
More Information about Transgenic on BioPortfolio
We have published hundreds of Transgenic news stories on BioPortfolio along with dozens of Transgenic Clinical Trials. In addition to the corporate data, news and clinical trials, BioPortfolio also has a large collection of PubMed Articles about Transgenic for you to read.
Showing "transgenics transgenic" Companies 1 to 25 of 54
NeuroVision Imaging, LLC (www.neurovision.com) was formed in 2010 and is headquartered in Sacramento, California. The Company develops digital imaging, and diagnostic solutions for Alzheimerâs disease (âADâ) and eye care markets. In a study published in NeuroImage by members of NVIâs founding team (under the direction of Dr. Keith Black...
Morflora develops generic and non-transgenic trait delivery solutions into plants, to protect them from a wide variety of diseases, as well as introduce new desired traits for plant enhancement. The company targets the seed and plant treatment markets, offering technology and solutions to increase global crop yield and reduce dependency on chemical treatme...
rEVO Biologics is a rare disease company focused on developing and delivering first and next-generation therapeutics that are more cost effective to produce than traditional recombinant therapies. Through its proprietary rPRO Technology platform -- a scalable, transgenic, and cost-effective method of protein production-- rEVO Biologics is bringing safe and...
Ablexis, LLC, was founded in December 2009 based on technology established by Aliva Biopharmaceuticals, Inc. Ablexis is developing the AlivaMab Mouse, an innovative, next-generation transgenic mouse platform intended to provide the foundation for the efficient discovery and development of the next wave of human therapeutic antibodies. Ablexis has filed pat...
In 1981, Mycogen Seeds started as a biotech company specializing in progressive transgenic research. We introduced the industry’s first corn hybrids resistant to European corn borer in 1996. Along the way, we acquired several companies and have grown to be an industry-leading seed brand.Today, Mycogen Seeds is headquartered in Indianapolis, Ind. and is your source for a superior selection o...
Until recently Nexia developed and manufactured complex recombinant proteins in the milk of transgenic goats for medical and industrial applications. The Company's two lead programs were Protexia and BioSteelR.On March 7, 2005, Nexia's, shareholders approved the sale of substantially all its operations and assets related to ProtexiaR to PharmAthene (www.pharmathene.com), a privately held biotechno...
Nucleis, Architect in Transgenesis
Nucleis, Architect in Transgenesis, is one of the leading biotech company focusing on custom made transgenic mice models. Thanks to its transgenic expertise, Nucleis offers a wide range of innovative approaches that helps researchers to better address gene discovery issues such as gene regulation and function, and optimise drug developments : gene over-expression, humanized mice, Knock-down (RNAi)...
Origen Therapeutics is a biotechnology company developing product opportunities arising from the emerging field of avian transgenic animal technology. The company's mission is to become the leading developer of a novel class human immunotherapeutics known as fully human sequence polyclonal antibodies. These antibodies are expected to have significant advantages over monoclonal antibodies that curr...
Ozgene staff have produced genetically modified (GM) mice and rats for global markets for nearly 20 years. GM mice and rats represent the most sophisticated and valuable tools in functional genomics and drug target validation.Ozgene provides a complete vector design and construction service followed by the generation of knockout, knockin and humanised mice, as well as transgenic and lentiviral tra...
Phycotransgenics, L.L.C is a biotechnology company that specializes in the development of transgenic algae that have market-driven properties. Markets that we are focusing on include animal health, animal feed, bioremediation, environmental monitoring and biopesticides. Research and Product Development. Our proficiency in the genetic manipulation and transformation of algae is the progenitor tech...
PolyGene is a privately held research institute, located in the area of Zurich, Switzerland. Founded in 2002, PolyGene is run by a team of scientists with academic and industrial backgrounds, having notable track records as well in mouse transgenesis as in business management.Since its inception, PolyGene has set up a fully functional production site for the establishment of transgenic mouse lines...
Strategic Diagnostics Inc., (Nasdaq: SDIX) headquartered in Newark, DE USA, is a biotechnology company dedicated to bringing innovative solutions to analytical testing problems through immunotechnology. SDI is a leading developer and manufacturer of immunoassay-based test kits for both field testing and laboratory use. These products are used extensively for contaminated waste site assessment and...
Sirtris Pharmaceuticals™ is a biopharmaceutical company developing and commercializing novel therapeutics that modulate sirtuins, a recently discovered family of enzymes that promotes the body's natural defense against disease. Also known as class III histone deacetylases (HDACs), sirtuins are attractive drug targets for diseases of aging, including metabolic and neurological diseases. Sirtris h...
Transnetyx is your molecular diagnostics company. Our automated genotyping service screens for transgenic, knock-out, and knock-in mutations in biopsies. We replace traditional genotyping with high throughput automation that allows your lab to save money and resources, increase staff productivity, and better focus on research goals.
TranXenoGen, Inc is a publicly traded biotechnology company listed on the Alternative Investment Market of the London Stock Exchange (TXN.L). The Company is focused on developing new methods for manufacturing therapeutic proteins and a portfolio of products. Its product pipeline includes Anti-Neoplastic Urinary Protein ("ANUP") for the treatment of several types of cancer, Insulin and Human Serum...
Triskel Integrated Services SA, based in Switzerland, has rapidly become the reference international pharmaceutical consultancy in Europe. We assist high-tech and biotech companies to analyse, determine and implement the most timely, cost-effective and efficient strategies to steer a molecule from discovery to the market.Triskel provides a strategic complement to CROs, contract manufacturers or ot...
Visgenyx Ltd was founded in 1999 by Prof. Alar Karis and Prof. Eero Vasar, both scientists at the University of Tartu, Estonia.An increasing demand for appropriate animal models for study of human diseases as well as an expertise have prompted the founders to start the Visgenyx company. Visgenyx unites knowledge of molecular and cell biologists, neurobiologists and physiologists thereby ensuring t...
Founded in 1998, Xenogen is the pioneer and leader in the field of biophotonic imaging. Xenogen's VivoVision Systems utilize biophotonic imaging and serve to expedite drug discovery and development, thereby minimizing up-front costs and significantly reducing the time to market for new therapies. Non-invasive in vivo biophotonic imaging illuminates biological processes taking place in a living mam...
Xenon is a privately held company located in Vancouver and has just over 70 employees. We are a leader in clinical genetic based drug discovery and development and have built a worldwide network of over 40 clinical collaborators to find and access the rare families with diseases of relevance to drug discovery. Our clinical genetic approaches are: Extreme Genetics TM: the analysis of rare families...
External Pharma, Inc. provides preclinical drug discovery and development support to pharmaceutical and biotech companies as fee for service or in collaboration with a partner. Our main focus is to evaluate drug candidates and targets for neurological and psychiatric indications. External Pharma represents the next generation of CROs - highly experienced drug development scientists working in a st...
4-Antibody is a biopharmaceutical company with a powerful fully-human antibody drug-discovery technology platform, which is generating an emerging pipeline of antibody therapeutics. The proprietary discovery engine is the in-vitro Retrocyte Display® technology, a fast and highly efficient source of antibody drug candidates. Retrocyte Display generates high quality therapeutic ant...
Open Monoclonal Technology, Inc.
Open Monoclonal Technology, Inc. (âOMTâ) is a private biotechnology company with a new, fully human monoclonal antibody platform based on transgenic rats. The rat is a widely used laboratory animal with a well characterized immune system, a nearly complete genome sequence, and established transgenesis and hybridoma technologies. OMTâs antibody...
Applied StemCell Inc. (ASC) is a fast growing biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics. Using our proprietary TARGATT™ gene modification technology, we make site-specific Knockin mouse, rat and human cell line models fast and efficient for pharmaceutical and academic community. Based on our Proprietary Technologies, we focus o...
GTC Biotherapeuticsâ core technology enables the development and manufacture of therapeutic proteins produced through transgenic animal technology. ATryn®, GTCâs recombinant human antithrombin, has been approved for use in the United States and Europe. ATryn is the first and only therapeutic product produced in transgenic animals to be approve...
SemBioSys Genetics Inc. (SBS.TSX) is a biotechnology company engaged in the development and commercialization of protein pharmaceutical and non-pharmaceutical products. PlatformOur proprietary protein production system addresses major commercialization challenges associated with the production of recombinant proteins; overcoming limitations in scale, capital and production costs. SemBioSys’ prop...
